Search Results for compound
Searching compound for Pyrazole-1-alanine returned 36219 results.
Displaying compounds 1126 - 1150 of 36219 in total
[(2R)-2,3-bis(hexadec-9-enoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched synonyms: … PI(16:1/16:1) ... PIno(16:1/16:1) ... Atidylinositol(16:1/16:1) …
Matched name: … PI(16:1(9Z)/16:1(9Z)) …
Matched description: … PI(16:1(9Z)/16:1(9Z))is a phosphatidylinositol. ... Fatty acids containing 18 and 20 carbons are the most common.PI(16:1(9Z)/16:1(9Z)), in particular, consists ... of two 9Z-hexadecenoyl chains at positions C-1 and C-2 to the C-2 atom. …
Matched name: … PI(16:1(9Z)/16:1(9Z)) …
Matched description: … PI(16:1(9Z)/16:1(9Z))is a phosphatidylinositol. ... Fatty acids containing 18 and 20 carbons are the most common.PI(16:1(9Z)/16:1(9Z)), in particular, consists ... of two 9Z-hexadecenoyl chains at positions C-1 and C-2 to the C-2 atom. …
{[(1R,3S)-3-({[(2R)-3-(hexadec-9-enoyloxy)-2-(octadec-11-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP(16:1/18:1) ... Atidylinositol ate(16:1/18:1) ... PIP[3'](16:1(9Z)/18:1(11Z)) …
Matched name: … PIP(16:1(9Z)/18:1(11Z)) …
Matched description: … PIP(16:1(9Z)/18:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(16:1(9Z)/18:1(11Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(16:1(9Z)/18:1(11Z)) …
Matched description: … PIP(16:1(9Z)/18:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(16:1(9Z)/18:1(11Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,3S)-3-({[(2R)-3-(hexadec-9-enoyloxy)-2-(octadec-9-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP[3'](16:1(9Z)/18:1(9Z)) ... 1-(9Z-Hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3'-ate) ... 1-(9Z-hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) …
Matched name: … PIP(16:1(9Z)/18:1(9Z)) …
Matched description: … PIP(16:1(9Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(16:1(9Z)/18:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(16:1(9Z)/18:1(9Z)) …
Matched description: … PIP(16:1(9Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(16:1(9Z)/18:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-3-(octadec-11-enoyloxy)-2-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP[3'](18:1(11Z)/18:1(9Z)) ... 1-(11Z-Octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3'-ate) ... 1-(11Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) …
Matched name: … PIP(18:1(11Z)/18:1(9Z)) …
Matched description: … PIP(18:1(11Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(18:1(11Z)/18:1(9Z)) …
Matched description: … PIP(18:1(11Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-(icos-11-enoyloxy)-3-(octadec-11-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched name: … PIP(18:1(15Z)/20:1(11Z)) …
Matched description: … Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids …
Matched description: … Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP[3'](18:1(9Z)/18:1(11Z)) ... 1-(9Z-Octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3'-ate) ... 1-(9Z-octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) …
Matched name: … PIP(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-3-(icos-11-enoyloxy)-2-(octadec-11-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched name: … PIP(20:1(11Z)/18:1(11Z)) …
Matched description: … Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids …
Matched description: … Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-3-(icos-11-enoyloxy)-2-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP(20:1/18:1) ... Atidylinositol ate(20:1/18:1) ... PIP[3'](20:1(11Z)/18:1(9Z)) …
Matched name: … PIP(20:1(11Z)/18:1(9Z)) …
Matched description: … PIP(20:1(11Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(20:1(11Z)/18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(20:1(11Z)/18:1(9Z)) …
Matched description: … PIP(20:1(11Z)/18:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(20:1(11Z)/18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(4S,6S)-4-({[(2R)-2,3-bis(hexadec-9-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,3,5-trihydroxy-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP2(16:1/16:1) ... Atidylinositol diate(16:1/16:1) ... PIP2[3',4'](16:1(9Z)/16:1(9Z)) …
Matched name: … PIP2(16:1(9Z)/16:1(9Z)) …
Matched description: … PIP2(16:1(9Z)/16:1(9Z)) is a phosphatidylinositol bisphosphate. ... PIP2(16:1(9Z)/16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP2(16:1(9Z)/16:1(9Z)) …
Matched description: … PIP2(16:1(9Z)/16:1(9Z)) is a phosphatidylinositol bisphosphate. ... PIP2(16:1(9Z)/16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(4S,6S)-4-({[(2R)-2,3-bis(octadec-11-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,3,5-trihydroxy-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP2(18:1/18:1) ... Atidylinositol diate(18:1/18:1) ... PIP2[3',4'](18:1(11Z)/18:1(11Z)) …
Matched name: … PIP2(18:1(11Z)/18:1(11Z)) …
Matched description: … PIP2(18:1(11Z)/18:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(11Z)/18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP2(18:1(11Z)/18:1(11Z)) …
Matched description: … PIP2(18:1(11Z)/18:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(11Z)/18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
[(2S)-2,3-dihydroxypropoxy][(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid
Matched synonyms: … 1-(9Z-Hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-glycerol) ... 1-(9Z-hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-glycerol) ... 1-Palmitoleoyl-2-oleoyl-sn-glycero-3-oglycerol …
Matched name: … PG(16:1(9Z)/18:1(9Z)) …
Matched description: … PG(16:1(9Z)/18:1(9Z)) is a phosphatidylglycerol. ... PG(16:1(9Z)/18:1(9Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one ... glycerol 3-phosphate backbone esterified to either saturated or unsaturated fatty acids on carbons 1 …
Matched name: … PG(16:1(9Z)/18:1(9Z)) …
Matched description: … PG(16:1(9Z)/18:1(9Z)) is a phosphatidylglycerol. ... PG(16:1(9Z)/18:1(9Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one ... glycerol 3-phosphate backbone esterified to either saturated or unsaturated fatty acids on carbons 1 …
[(2S)-2,3-dihydroxypropoxy][(2R)-3-(octadec-11-enoyloxy)-2-(octadec-9-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … 1-(11Z-Octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-glycerol) ... 1-(11Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-glycerol) ... 1-Vaccenoyl-2-oleoyl-sn-glycero-3-oglycerol …
Matched name: … PG(18:1(11Z)/18:1(9Z)) …
Matched description: … PG(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... PG(18:1(11Z)/18:1(9Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PG(18:1(11Z)/18:1(9Z)) …
Matched description: … PG(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... PG(18:1(11Z)/18:1(9Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-1,3-dihydroxypropyl]-5-acetamido-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxyoxane-2-carboxylic acid
Matched name: … Ganglioside GD1b (d18:1/26:1(17Z)) …
Matched iupac: … -2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1b (d18:1/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1b (d18:1/26:1(17Z)) is a GD1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … -2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1b (d18:1/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1b (d18:1/26:1(17Z)) is a GD1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD2 (d18:1/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD2 (d18:1/22:1(13Z)) is a GD2 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD2 (d18:1/22:1(13Z)) is a GD2 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1-yl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM3 (d18:1/18:1(11Z)) …
Matched iupac: … ,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GM3 (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:1/18:1(11Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … ,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GM3 (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:1/18:1(11Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT1b (d18:1/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GT1b (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1b (d18:1/22:1(13Z)) is a GT1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GT1b (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1b (d18:1/22:1(13Z)) is a GT1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(tetracos-15-enamido)octadec-4-en-1-yl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT1b (d18:1/24:1(15Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S ... yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(tetracos-15-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GT1b (d18:1/24:1(15Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1b (d18:1/24:1(15Z)) is a GT1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S ... yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(tetracos-15-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GT1b (d18:1/24:1(15Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1b (d18:1/24:1(15Z)) is a GT1b ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1-yl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT1c (d18:1/18:1(11Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1-yl]oxy …
Matched description: … Ganglioside GT1c (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1c (d18:1/18:1(11Z)) is a GT1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1-yl]oxy …
Matched description: … Ganglioside GT1c (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1c (d18:1/18:1(11Z)) is a GT1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT1c (d18:1/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy …
Matched description: … Ganglioside GT1c (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1c (d18:1/22:1(13Z)) is a GT1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4R,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy …
Matched description: … Ganglioside GT1c (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT1c (d18:1/22:1(13Z)) is a GT1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT2 (d18:1/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GT2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT2 (d18:1/22:1(13Z)) is a GT2 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S ... oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GT2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT2 (d18:1/22:1(13Z)) is a GT2 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-9-enamido)octadec-4-en-1-yl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT3 (d18:1/18:1(9Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-9-enamido)octadec-4-en-1-yl]oxy …
Matched description: … Ganglioside GT3 (d18:1/18:1(9Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT3 (d18:1/18:1(9Z)) is a GT3 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-9-enamido)octadec-4-en-1-yl]oxy …
Matched description: … Ganglioside GT3 (d18:1/18:1(9Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT3 (d18:1/18:1(9Z)) is a GT3 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GT3 (d18:1/22:1(13Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy …
Matched description: … Ganglioside GT3 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT3 (d18:1/22:1(13Z)) is a GT3 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2S,3R,4S,5S,6R ... )-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy …
Matched description: … Ganglioside GT3 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GT3 (d18:1/22:1(13Z)) is a GT3 ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S)-2-amino-3-({[(2R)-2-(hexadec-9-enoyloxy)-3-(tetradec-9-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid
Matched synonyms: … PS(14:1/16:1) ... PSer(14:1/16:1) ... Atidylserine(14:1/16:1) …
Matched name: … PS(14:1(9Z)/16:1(9Z)) …
Matched description: … PS(14:1(9Z)/16:1(9Z)) is a phosphatidylserine. ... PS(14:1(9Z)/16:1(9Z)), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …
Matched name: … PS(14:1(9Z)/16:1(9Z)) …
Matched description: … PS(14:1(9Z)/16:1(9Z)) is a phosphatidylserine. ... PS(14:1(9Z)/16:1(9Z)), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …
(2S)-2-amino-3-({[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid
Matched synonyms: … PS(16:1/18:1) ... PSer(16:1/18:1) ... Atidylserine(16:1/18:1) …
Matched name: … PS(16:1(9Z)/18:1(9Z)) …
Matched description: … PS(16:1(9Z)/18:1(9Z)) is a phosphatidylserine. ... PS(16:1(9Z)/18:1(9Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …
Matched name: … PS(16:1(9Z)/18:1(9Z)) …
Matched description: … PS(16:1(9Z)/18:1(9Z)) is a phosphatidylserine. ... PS(16:1(9Z)/18:1(9Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …
(2S)-2-amino-3-({hydroxy[(2R)-3-(octadec-9-enoyloxy)-2-(tetradec-9-enoyloxy)propoxy]phosphoryl}oxy)propanoic acid
Matched synonyms: … PS(18:1/14:1) ... PSer(18:1/14:1) ... Atidylserine(18:1/14:1) …
Matched name: … PS(18:1(9Z)/14:1(9Z)) …
Matched description: … PS(18:1(9Z)/14:1(9Z)) is a phosphatidylserine. ... PS(18:1(9Z)/14:1(9Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …
Matched name: … PS(18:1(9Z)/14:1(9Z)) …
Matched description: … PS(18:1(9Z)/14:1(9Z)) is a phosphatidylserine. ... PS(18:1(9Z)/14:1(9Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one ... Phosphatidylserines typically carry a net charge of -1 at physiological pH. …